免疫微环境和与免疫相关的疗法在患有 pseudomyxoma peritonei 的患者中的进展
Qidi Zhao1,2, Tian Wei1,2, Ru Ma3
1School of Clinical Medicine, Tsinghua University, Beijing 100084, China.
Cancer biology & medicine
|July 19, 2024
概括
皮瘤 (Pseudomyxoma peritonei,简称PMP) 是一种罕见的癌症. 本综述讨论了GNAS突变,粘素分泌和PMP的免疫疗法策略,强调了对新型治疗的需求.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 皮瘤 (Pseudomyxoma peritonei,简称PMP) 是一种在标准细胞减小手术和腹腔内高热化疗 (CRS+HIPEC) 后具有高复发率的惰性恶性瘤.
- 先进的PMP阶段经常显示,由于扩散转移,CRS + HIPEC的益处有限.
- 由GNAS突变加剧的渐进性粘液硬化症是一个重大的治疗挑战.
研究的目的:
- 审查GNAS突变在促进粘素分泌和PMP进展中的作用.
- 讨论PMP微环境的免疫特征.
- 为了探索潜在的免疫相关治疗PMP.
主要方法:
- 文献综述侧重于GNAS突变,粘素生物学和PMP免疫学.
- 分析当前和新兴的免疫治疗策略.
- 综合现有知识,以确定差距和未来方向.
主要成果:
- GNAS突变与增加的粘素分泌有关,有助于PMP的发展和进展.
- 瘤PMP微环境表现出特定的免疫学特征.
- 包括细菌剂和新抗原在内的各种与免疫相关的疗法,在临床前表现有希望,但缺乏确定的临床认可.
结论:
- 针对GNAS突变和了解PMP免疫微环境对于开发新疗法至关重要.
- 迫切需要进一步研究免疫疗法,以改善PMP患者的治疗结果.
- 开发有效的免疫疗法可以克服当前治疗方法的局限性,并解决疾病复发.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504